tiprankstipranks
Enliven Therapeutics (ELVN)
NASDAQ:ELVN
US Market

Enliven Therapeutics (ELVN) Balance Sheet

267 Followers

Enliven Therapeutics Balance Sheet

Enliven Therapeutics's total assets for Q1 2024 were $342.78M, an increase of 25.08% from the previous quarter. ELVN total liabilities were $25.07M for the fiscal quarter, a 103.90% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Jan 23Dec 22Dec 21Dec 20
Total Assets
$ 271.87M-$ 91.96M$ 93.65M$ 90.84M
Total Liabilities
$ 25.96M-$ 1.83M$ 7.62M$ 6.41M
Total Equity Gross Minority
$ 245.91M-$ 90.14M$ 86.03M$ 84.44M
Total Capitalization
$ 245.91M-$ 90.13M$ 86.03M$ 84.44M
Preferred Stock Equity
-----
Capital Lease Obligations
----$ 0.00
Currency in USD

Enliven Therapeutics Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis